GTF2I and cancer: Non-recurrent, cancer-specific mutations (n = 28 genes across 11 cancers; Fig. 2c) predominantly correlated with high telomerase activity, with notable exceptions including PPP2R1A in UCS, HRAS, and GTF2I in THYM and SMAD4 in PAAD.